{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To reduce acute inflammation and accelerate recovery from the relapse Patient has significant functional deficits (vision loss and gait instability)\n\n*   **Treatment:** Gastroprotection (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Prophylaxis against gastritis/ulceration while on high-dose steroids\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Infliximab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Must await definitive diagnosis (MS vs Neurosarcoidosis) as treatments differ Must exclude active infection before commencing immunosuppression\n\n*   **Treatment:** Physiotherapy and Occupational Therapy\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To assist with gait safety and rehabilitation of motor deficits\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"To reduce acute inflammation and accelerate recovery from the relapse\", \"Patient has significant functional deficits (vision loss and gait instability)\"]}, {\"treatment\": \"Gastroprotection (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Prophylaxis against gastritis/ulceration while on high-dose steroids\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Infliximab)\", \"timing\": \"Delay\", \"reasons\": [\"Must await definitive diagnosis (MS vs Neurosarcoidosis) as treatments differ\", \"Must exclude active infection before commencing immunosuppression\"]}, {\"treatment\": \"Physiotherapy and Occupational Therapy\", \"timing\": \"Start Now\", \"reasons\": [\"To assist with gait safety and rehabilitation of motor deficits\"]}]"
}